glp 1 agonist risks GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies NEW: A systematic review found

Most intestinal K cells secrete a biologically active form of GIP consisting of 42 amino acids, GIP (42), which is derived from a 153 amino acid preprohormone precursor distinct from preproglucagon ( Figure 2 ]

We did not include a study by Anazco et al because it did not compare GLP-1RA users to nonusers

Cannot be used in pregnant and lactating women

To support this, clinicians should emphasize a diversity of nutrient-dense, minimally processed foods such as fruits, vegetables, whole grains, legumes, lean proteins, nuts, and seeds

The prolonged satiety it provides has made it easier to stick to my reduced-calorie diet

Arguably, the most clinically relevant basis for the potential of GLP-1 RAs in HF could be their effect on multiple cardiometabolic parameters that play intertwined roles across the HF-related diseases such as diabetes and obesity, which often co-exist